contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


coalalife-signs-an-agreement-with-an-us-clinic-to-monitor-an-initial-400-patients-under-rpm-and-pcm

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Coala-Life Group

CoalaLife has signed an agreement with a prominent cardiology practice for RPM, PCM and billing services. The program was started upon signing and is expected to expand to over 2.000 patients...

<div class="mfn-body"><p>CoalaLife has signed an agreement with a prominent cardiology practice for RPM, PCM and billing services. The program was started upon signing and is expected to expand to over 2.000 patients during the first half of 2024. The practice will also utilize the Coala Heart Monitor as an unique addition to their standard diagnostic technologies.<br>&nbsp;<br><em>“Our comprehensive offering, proprietary framework and our Coala Heart Monitor has positioned the Company as a leader within the RPM/PCM market. With our robust customer pipeline we are looking forward to an exciting 2024”</em> says CEO Dan Pitulia.</p></div><div class="mfn-footer mfn-contacts mfn-efeae9775a6c"><p><strong class="mfn-heading-1">About us</strong></p><hr><p>Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015, is a Cloud Based Software as a Service provider, and medical device developer and reseller, listed on Nasdaq First North Growth Market. The Company focuses on&nbsp;B2B&nbsp;solutions for&nbsp;managed Remote Patient Monitoring (“RPM”), offering medical care providers, primarily in the US, with a highly scalable, cost-efficient platform&nbsp;to&nbsp;remotely and virtually&nbsp;manage&nbsp;large volumes of&nbsp;patients suffering from chronic diseases.&nbsp;The company offers care providers a comprehensive solution and lifts the administrative work from the care providers regarding, amongst other things, follow-up, 24/7 monitoring, as well as the reimbursement process from state and private health insurance companies. Patients are monitored long-term in everyday life and typically have&nbsp;diabetes, obesity,&nbsp;and/or&nbsp;cardiovascular disease.&nbsp;<br>For more information see <strong><a rel="noopener" href="https://www.coalalife.com/us/">www.coalalife.com</a></strong></p></div><div class="mfn-footer mfn-about mfn-c3f0800fca7b"><p><strong class="mfn-heading-1">For more information, please contact:</strong></p><hr><p>Dan Pitulia, CEO Coala Life AB<br>+44 7849 257 532,&nbsp;<strong><a rel="noopener" href="mailto:dan.pitulia@coalalife.com">dan.pitulia@coalalife.com</a></strong><br>Robin Danielsson Källmark, Interim CFO Coala Life AB<br>+46 72 188 84 09,&nbsp;<strong><a rel="noopener" href="mailto:robin.danielsson.kallmark@coalalife.com">robin.danielsson.kallmark@coalalife.com</a></strong></p><p>Certified Adviser<br>The Company’s Certified Adviser is Carnegie Investment Bank AB (publ).<br></p></div><div class="mfn-footer mfn-regulatory mfn-regulatory-mar"><p><em>This information is information that Coala Life is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-01-10 08:50 CET.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/dd580f1c-5d06-415c-86c5-b53fcf8defde/coalalife-signs-an-agreement-with-an-us-clinic-to-monitor-an-initial-400-patients-under-rpm-and-pcm.pdf" class="mfn-generated mfn-primary">CoalaLife signs an agreement with an US clinic to monitor an initial 400 patients under RPM and PCM</a></p></div>

CoalaLife signs an agreement with an US clinic to monitor an initial 400 patients under RPM and PCM